Physical vitrification and nanowarming at liter-scale CPA volumes: toward organ cryopreservation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41006284.
- Also identified by DOI 10.1038/s41467-025-63483-2 and PMC identifier 12474906.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Organ banking via vitrification could transform transplantation, but has never been achieved at human organ scales. This study tested vitrification and rewarming in 0.5-3 L volumes using cryoprotective agents (CPAs): M22, VS55, and 40%EG + 0.6 M Sucrose. Ice formation and cracking was avoided through optimized convective cooling, and successful vitrification was confirmed via visual inspection, thermometry, and X-ray µCT. M22 and EG+sucrose vitrified at 0.5 L, but only M22 succeeded at 3 L; VS55 failed at all volumes. Porcine livers (~0.6-1 L total volume; ~0.23-0.75 L organ volume) were also vitrified using EG+sucrose, though not rewarmed. Future experiments are needed to optimize the protocol and achieve liver rewarming. Using nanowarming with iron-oxide nanoparticles and a newly developed 120 kW RF coil, uniform rewarming was achieved in up to 2 L volumes of M22 at ~88 °C/min. This work serves as a proof-of-concept that human organ scale vitrification and rewarming is physically possible, thereby enabling human organ banking in the future.
Medical subject headings
- Vitrification
- Cryopreservation
- Cryoprotective Agents
- Liver
- Organ Preservation